Birgit C. Schultes - EVP, Chief Scientific Officer at Intellia Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Scientific Officer
Issuer Symbol
NTLA on Nasdaq
All Insider Reports
All Insider Reports

Birgit C. Schultes - trading volume in the past year for Intellia Therapeutics, Inc.

Holdings reported by Birgit C. Schultes for Intellia Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 137,733 $1,720,285 $12.49 01 Mar 2026 Direct
Stock Option (right to buy) 56,000 01 Mar 2026 Direct Common Stock

Transactions reported by Birgit C. Schultes for Intellia Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.